{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,29]],"date-time":"2024-02-29T12:07:24Z","timestamp":1709208444823},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2022,4,9]],"date-time":"2022-04-09T00:00:00Z","timestamp":1649462400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,4,9]],"date-time":"2022-04-09T00:00:00Z","timestamp":1649462400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Internist"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1007\/s00108-022-01323-x","type":"journal-article","created":{"date-parts":[[2022,4,9]],"date-time":"2022-04-09T21:02:16Z","timestamp":1649538136000},"page":"557-565","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Sarkoidose und Berylliose"],"prefix":"10.1007","volume":"63","author":[{"given":"Daniel","family":"Soriano","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caroline","family":"Quartucci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prerana","family":"Agarwal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joachim","family":"M\u00fcller-Quernheim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bj\u00f6rn Christian","family":"Frye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,4,9]]},"reference":[{"key":"1323_CR1","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1055\/s-0034-1376866","volume":"35","author":"H Adams","year":"2014","unstructured":"Adams\u00a0H, Keijsers\u00a0RG, Korenromp\u00a0IH, Grutters\u00a0JC (2014) FDG PET for gauging of sarcoid disease activity. Semin Respir Crit Care Med 35:352\u2013361","journal-title":"Semin Respir Crit Care Med"},{"key":"1323_CR2","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1159\/000481827","volume":"95","author":"T Bahmer","year":"2018","unstructured":"Bahmer\u00a0T, Watz\u00a0H, Develaska\u00a0M, Waschki\u00a0B, Rabe\u00a0KF, Magnussen\u00a0H, Kirsten\u00a0D, Kirsten\u00a0AM (2018) Physical activity and fatigue in patients with sarcoidosis. Respiration 95:18\u201326","journal-title":"Respiration"},{"key":"1323_CR3","doi-asserted-by":"publisher","first-page":"e34","DOI":"10.1164\/rccm.201409-1722ST","volume":"190","author":"JR Balmes","year":"2014","unstructured":"Balmes\u00a0JR, Abraham\u00a0JL, Dweik\u00a0RA, Fireman\u00a0E, Fontenot\u00a0AP, Maier\u00a0LA, Muller-Quernheim\u00a0J, Ostiguy\u00a0G, Pepper\u00a0LD, Saltini\u00a0C, Schuler\u00a0CR, Takaro\u00a0TK, Wambach\u00a0PF, Sensitivity ATSAHCoB, Chronic Beryllium D (2014) An official American Thoracic Society statement: diagnosis and management of beryllium sensitivity and chronic beryllium disease. Am J Respir Crit Care Med 190:e34\u2013e59","journal-title":"Am J Respir Crit Care Med"},{"key":"1323_CR4","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1164\/rccm.200603-402OC","volume":"174","author":"RP Baughman","year":"2006","unstructured":"Baughman\u00a0RP, Drent\u00a0M, Kavuru\u00a0M, Judson\u00a0MA, Costabel\u00a0U, du Bois\u00a0R, Albera\u00a0C, Brutsche\u00a0M, Davis\u00a0G, Donohue\u00a0JF, Muller-Quernheim\u00a0J, Schlenker-Herceg\u00a0R, Flavin\u00a0S, Lo\u00a0KH, Oemar\u00a0B, Barnathan\u00a0ES, Sarcoidosis I (2006) Infliximab therapy in patients with chronic sarcoidosis and pulmonary involvement. Am J Respir Crit Care Med 174:795\u2013802","journal-title":"Am J Respir Crit Care Med"},{"key":"1323_CR5","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1097\/MCP.0000000000000303","volume":"22","author":"CE Broos","year":"2016","unstructured":"Broos\u00a0CE, Hendriks\u00a0RW, Kool\u00a0M (2016) T\u2011cell immunology in sarcoidosis: disruption of a\u00a0delicate balance between helper and regulatory T\u2011cells. Curr Opin Pulm Med 22:476\u2013483","journal-title":"Curr Opin Pulm Med"},{"key":"1323_CR6","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1055\/s-0034-1376859","volume":"35","author":"ES Chen","year":"2014","unstructured":"Chen\u00a0ES, Moller\u00a0DR (2014) Etiologic role of infectious agents. Semin Respir Crit Care Med 35:285\u2013295","journal-title":"Semin Respir Crit Care Med"},{"key":"1323_CR7","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1111\/joim.12991","volume":"288","author":"F Cohen Aubart","year":"2020","unstructured":"Cohen Aubart\u00a0F, Lhote\u00a0R, Amoura\u00a0A, Valeyre\u00a0D, Haroche\u00a0J, Amoura\u00a0Z, Lebrun-Vignes\u00a0B (2020) Drug-induced sarcoidosis: an overview of the WHO pharmacovigilance database. J\u00a0Intern Med 288:356\u2013362","journal-title":"J Intern Med"},{"key":"1323_CR8","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.rmed.2016.04.011","volume":"115","author":"HA Crommelin","year":"2016","unstructured":"Crommelin\u00a0HA, van der Burg\u00a0LM, Vorselaars\u00a0AD, Drent\u00a0M, van Moorsel\u00a0CH, Rijkers\u00a0GT, Deneer\u00a0VH, Grutters\u00a0JC (2016) Efficacy of adalimumab in sarcoidosis patients who developed intolerance to infliximab. Respir Med 115:72\u201377","journal-title":"Respir Med"},{"key":"1323_CR9","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.resinv.2013.01.001","volume":"51","author":"Y Eishi","year":"2013","unstructured":"Eishi\u00a0Y (2013) Etiologic link between sarcoidosis and propionibacterium acnes. Respir Investig 51:56\u201368","journal-title":"Respir Investig"},{"key":"1323_CR10","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1055\/s-0032-1332900","volume":"138","author":"U Euler","year":"2013","unstructured":"Euler\u00a0U, Dahmann\u00a0D, Follmann\u00a0M, Gaede\u00a0KI, Gassler\u00a0A, Groneberg\u00a0D, Heger\u00a0M, Krutz\u00a0K, Latza\u00a0U, Lelgemann\u00a0M, Letzel\u00a0S, Merget\u00a0R, Muller-Quernheim\u00a0J, Nauert\u00a0T, Seidler\u00a0A, Deutsche Gesellschaft fur Arbeitsmedizin und Umweltmedizin e V (2013) Health surveillance for workers exposed to beryllium and diagnostic procedures in beryllium-associated diseases. Dtsch Med Wochenschr 138:488\u2013492","journal-title":"Dtsch Med Wochenschr"},{"key":"1323_CR11","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s12955-019-1131-z","volume":"17","author":"E Farin","year":"2019","unstructured":"Farin\u00a0E, Heyduck\u00a0K, Frye\u00a0BC, Birring\u00a0SS, Muller-Quernheim\u00a0J, Schupp\u00a0JC (2019) Translation and psychometric properties of the King\u2019s Sarcoidosis Questionnaire (KSQ) in German language. Health Qual Life Outcomes 17:62","journal-title":"Health Qual Life Outcomes"},{"key":"1323_CR12","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1055\/s-0034-1376860","volume":"35","author":"A Fischer","year":"2014","unstructured":"Fischer\u00a0A, Grunewald\u00a0J, Spagnolo\u00a0P, Nebel\u00a0A, Schreiber\u00a0S, Muller-Quernheim\u00a0J (2014) Genetics of sarcoidosis. Semin Respir Crit Care Med 35:296\u2013306","journal-title":"Semin Respir Crit Care Med"},{"key":"1323_CR13","doi-asserted-by":"publisher","first-page":"22","DOI":"10.4049\/jimmunol.1502011","volume":"196","author":"AP Fontenot","year":"2016","unstructured":"Fontenot\u00a0AP, Falta\u00a0MT, Kappler\u00a0JW, Dai\u00a0S, McKee\u00a0AS (2016) Beryllium-induced hypersensitivity: genetic susceptibility and neoantigen generation. J\u00a0Immunol 196:22\u201327","journal-title":"J Immunol"},{"key":"1323_CR14","doi-asserted-by":"publisher","first-page":"2573","DOI":"10.1056\/NEJMc2000343","volume":"382","author":"BC Frye","year":"2020","unstructured":"Frye\u00a0BC, Meiss\u00a0F, von Bubnoff\u00a0D, Zissel\u00a0G, Muller-Quernheim\u00a0J (2020) Vasoactive intestinal peptide in checkpoint inhibitor-induced pneumonitis. N\u00a0Engl J Med 382:2573\u20132574","journal-title":"N Engl J Med"},{"issue":"3","key":"1323_CR15","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1016\/j.chest.2020.09.073","volume":"159","author":"BC Frye","year":"2021","unstructured":"Frye BC, Quartucci C, Rakete S, Grubanovic A, Hohne K, Mangold F, Giere R, Muller-Quernheim J, Zissel G (2021) A cluster of beryllium sensitization traced to the presence of beryllium in concrete dust. Chest 159(3):1084\u20131093","journal-title":"Chest"},{"key":"1323_CR16","doi-asserted-by":"publisher","first-page":"100575","DOI":"10.1016\/j.conctc.2020.100575","volume":"19","author":"BC Frye","year":"2020","unstructured":"Frye\u00a0BC, Rump\u00a0IC, Uhlmann\u00a0A, Schubach\u00a0F, Ihorst\u00a0G, Grimbacher\u00a0B, Zissel\u00a0G, Quernheim\u00a0JM (2020) Safety and efficacy of abatacept in patients with treatment-resistant SARCoidosis (ABASARC)\u2014protocol for a\u00a0multi-center, single-arm phase IIa trial. Contemp Clin Trials Commun 19:100575","journal-title":"Contemp Clin Trials Commun"},{"key":"1323_CR17","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/s41572-019-0096-x","volume":"5","author":"J Grunewald","year":"2019","unstructured":"Grunewald\u00a0J, Grutters\u00a0JC, Arkema\u00a0EV, Saketkoo\u00a0LA, Moller\u00a0DR, Muller-Quernheim\u00a0J (2019) Sarcoidosis. Nat Rev Dis Primers 5:45","journal-title":"Nat Rev Dis Primers"},{"key":"1323_CR18","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/j.jaad.2020.10.016","volume":"84","author":"KL Kerkemeyer","year":"2021","unstructured":"Kerkemeyer\u00a0KL, Meah\u00a0N, Sinclair\u00a0RD (2021) Tofacitinib for cutaneous and pulmonary sarcoidosis: a case series. J\u00a0Am Acad Dermatol 84:581\u2013583","journal-title":"J Am Acad Dermatol"},{"key":"1323_CR19","doi-asserted-by":"publisher","DOI":"10.12688\/f1000research.11068.1","volume-title":"Is it time to scrap Scadding and adopt computed tomography for initial evaluation of sarcoidosis? F1000Res","author":"A Levy","year":"2018","unstructured":"Levy A, Hamzeh N, Maier LA (2018) Is it time to scrap Scadding and adopt computed tomography for initial evaluation of sarcoidosis? F1000Res. https:\/\/doi.org\/10.12688\/f1000research.11068.1"},{"key":"1323_CR20","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1128\/CVI.00337-10","volume":"18","author":"MJ Loza","year":"2011","unstructured":"Loza\u00a0MJ, Brodmerkel\u00a0C, Du Bois\u00a0RM, Judson\u00a0MA, Costabel\u00a0U, Drent\u00a0M, Kavuru\u00a0M, Flavin\u00a0S, Lo\u00a0KH, Barnathan\u00a0ES, Baughman\u00a0RP (2011) Inflammatory profile and response to anti-tumor necrosis factor therapy in patients with chronic pulmonary sarcoidosis. Clin Vaccine Immunol 18:931\u2013939","journal-title":"Clin Vaccine Immunol"},{"key":"1323_CR21","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1183\/09031936.06.00112205","volume":"27","author":"J M\u00fcller-Quernheim","year":"2006","unstructured":"M\u00fcller-Quernheim\u00a0J, Gaede\u00a0KI, Fireman\u00a0E, Zissel\u00a0G (2006) Diagnoses of chronic beryllium disease within cohorts of sarcoidosis patients. Eur Respir\u00a0J 27:1190\u20131195","journal-title":"Eur Respir J"},{"issue":"9","key":"1323_CR22","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.3390\/jcm8091327","volume":"8","author":"C Pedro","year":"2019","unstructured":"Pedro C, Melo N, Novais EBH, Magalhaes A, Fernandes G, Martins N, Morais A, Mota CP (2019) Role of bronchoscopic techniques in the diagnosis of thoracic Sarcoidosis. J\u00a0Clin Med 8(9):1327. https:\/\/doi.org\/10.3390\/jcm8091327","journal-title":"J\u00a0Clin Med"},{"issue":"155","key":"1323_CR23","doi-asserted-by":"publisher","first-page":"190146","DOI":"10.1183\/16000617.0146-2019","volume":"29","author":"FF Rahaghi","year":"2020","unstructured":"Rahaghi FF, Baughman RP, Saketkoo LA, Sweiss NJ, Barney JB, Birring SS, Costabel U, Crouser ED, Drent M, Gerke AK, Grutters JC, Hamzeh NY, Huizar I, Wt EJ, Kalra S, Kullberg S, Li H, Lower EE, Maier LA, Mirsaeidi M, Muller-Quernheim J, Carmona Porquera EM, Samavati L, Valeyre D, Scholand MB (2020) Delphi consensus recommendations for a\u00a0treatment algorithm in pulmonary sarcoidosis. Eur Respir Rev 29(155):190146. https:\/\/doi.org\/10.1183\/16000617.0146-2019","journal-title":"Eur Respir Rev"},{"key":"1323_CR24","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1126\/science.8105536","volume":"262","author":"L Richeldi","year":"1993","unstructured":"Richeldi\u00a0L, Sorrentino\u00a0R, Saltini\u00a0C (1993) HLA-DPB 1 glutamate 69: a\u00a0genetic marker of beryllium disease. Science 262:242\u2013244","journal-title":"Science"},{"issue":"2","key":"1323_CR25","doi-asserted-by":"publisher","first-page":"1701815","DOI":"10.1183\/13993003.01815-2017","volume":"51","author":"M Rossides","year":"2018","unstructured":"Rossides M, Kullberg S, Askling J, Eklund A, Grunewald J, Arkema EV (2018) Sarcoidosis mortality in Sweden: a\u00a0population-based cohort study. Eur Respir\u00a0J 51(2):1701815. https:\/\/doi.org\/10.1183\/13993003.01815-2017","journal-title":"Eur Respir\u00a0J"},{"key":"1323_CR26","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1111\/resp.14001","volume":"26","author":"M Rossides","year":"2021","unstructured":"Rossides\u00a0M, Kullberg\u00a0S, Di Giuseppe\u00a0D, Eklund\u00a0A, Grunewald\u00a0J, Askling\u00a0J, Arkema\u00a0EV (2021) Infection risk in sarcoidosis patients treated with methotrexate compared to azathioprine: A retrospective \u2018target trial\u2019 emulated with Swedish real-world data. Respirology 26:452\u2013460","journal-title":"Respirology"},{"key":"1323_CR27","doi-asserted-by":"publisher","first-page":"S7","DOI":"10.1016\/j.rmed.2018.02.009","volume":"138S","author":"MC Schimmelpennink","year":"2018","unstructured":"Schimmelpennink\u00a0MC, Vorselaars\u00a0ADM, van Beek\u00a0FT, Crommelin\u00a0HA, Deneer\u00a0VHM, Keijsers\u00a0RGM, Veltkamp\u00a0M (2018) Efficacy and safety of infliximab biosimilar Inflectra((R)) in severe sarcoidosis. Respir Med 138S:S7\u2013S13","journal-title":"Respir Med"},{"key":"1323_CR28","doi-asserted-by":"publisher","first-page":"e0205308","DOI":"10.1371\/journal.pone.0205308","volume":"13","author":"JC Schupp","year":"2018","unstructured":"Schupp\u00a0JC, Fichtner\u00a0UA, Frye\u00a0BC, Heyduck-Weides\u00a0K, Birring\u00a0SS, Windisch\u00a0W, Criee\u00a0CP, Muller-Quernheim\u00a0J, Farin\u00a0E (2018) Psychometric properties of the German version of the Leicester Cough Questionnaire in sarcoidosis. PLoS ONE 13:e205308","journal-title":"PLoS ONE"},{"key":"1323_CR29","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/j.ebiom.2016.04.024","volume":"8","author":"Y Shen","year":"2016","unstructured":"Shen\u00a0Y, Pang\u00a0C, Wu\u00a0Y, Li\u00a0D, Wan\u00a0C, Liao\u00a0Z, Yang\u00a0T, Chen\u00a0L, Wen\u00a0F (2016) Diagnostic performance of bronchoalveolar lavage fluid CD4\/CD8 ratio for Sarcoidosis: a meta-analysis. EBioMedicine 8:302\u2013308","journal-title":"EBioMedicine"},{"key":"1323_CR30","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1055\/a-1031-4588","volume":"74","author":"D Skowasch","year":"2020","unstructured":"Skowasch\u00a0D, Gaertner\u00a0F, Marx\u00a0N, Meder\u00a0B, Muller-Quernheim\u00a0J, Pfeifer\u00a0M, Schrickel\u00a0JW, Yilmaz\u00a0A, Grohe\u00a0C (2020) Diagnostics and Treatment of Cardiac Sarcoidosis\u2014Consensus Paper of the German Respiratory Society (DGP) and the German Cardiac Society (DGK). Pneumologie 74:24\u201334","journal-title":"Pneumologie"},{"key":"1323_CR31","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1183\/09031936.00224513","volume":"43","author":"NJ Sweiss","year":"2014","unstructured":"Sweiss\u00a0NJ, Lower\u00a0EE, Mirsaeidi\u00a0M, Dudek\u00a0S, Garcia\u00a0JG, Perkins\u00a0D, Finn\u00a0PW, Baughman\u00a0RP (2014) Rituximab in the treatment of refractory pulmonary sarcoidosis. Eur Respir\u00a0J 43:1525\u20131528","journal-title":"Eur Respir J"},{"key":"1323_CR32","doi-asserted-by":"publisher","first-page":"809","DOI":"10.12998\/wjcc.v7.i7.809","volume":"7","author":"C Tana","year":"2019","unstructured":"Tana\u00a0C, Schiavone\u00a0C, Ticinesi\u00a0A, Ricci\u00a0F, Giamberardino\u00a0MA, Cipollone\u00a0F, Silingardi\u00a0M, Meschi\u00a0T, Dietrich\u00a0CF (2019) Ultrasound imaging of abdominal sarcoidosis: state of the art. World J Clin Cases 7:809\u2013818","journal-title":"World J Clin Cases"},{"issue":"155","key":"1323_CR33","doi-asserted-by":"publisher","first-page":"190057","DOI":"10.1183\/16000617.0057-2019","volume":"29","author":"R Vis","year":"2020","unstructured":"Vis R, van de Garde EMW, Grutters JC, Korenromp IHE (2020) The effects of pharmacological interventions on quality of life and fatigue in sarcoidosis: a\u00a0systematic review. Eur Respir Rev 29(155):190057. https:\/\/doi.org\/10.1183\/16000617.0057-2019","journal-title":"Eur Respir Rev"},{"key":"1323_CR34","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1097\/MCP.0000000000000078","volume":"20","author":"AD Vorselaars","year":"2014","unstructured":"Vorselaars\u00a0AD, Cremers\u00a0JP, Grutters\u00a0JC, Drent\u00a0M (2014) Cytotoxic agents in sarcoidosis: which one should we choose? Curr Opin Pulm Med 20:479\u2013487","journal-title":"Curr Opin Pulm Med"},{"key":"1323_CR35","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1164\/ajrccm.156.5.97-02050","volume":"156","author":"MW Ziegenhagen","year":"1997","unstructured":"Ziegenhagen\u00a0MW, Benner\u00a0UK, Zissel\u00a0G, Zabel\u00a0P, Schlaak\u00a0M, Muller-Quernheim\u00a0J (1997) Sarcoidosis: TNF-alpha release from alveolar macrophages and serum level of sIL-2R are prognostic markers. Am J Respir Crit Care Med 156:1586\u20131592","journal-title":"Am J Respir Crit Care Med"},{"key":"1323_CR36","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1046\/j.1365-2796.2000.00685.x","volume":"248","author":"MW Ziegenhagen","year":"2000","unstructured":"Ziegenhagen\u00a0MW, Fitschen\u00a0J, Martinet\u00a0N, Schlaak\u00a0M, Muller-Quernheim\u00a0J (2000) Serum level of soluble tumour necrosis factor receptor II (75\u202fkDa) indicates inflammatory activity of sarcoidosis. J\u00a0Intern Med 248:33\u201341","journal-title":"J Intern Med"},{"key":"1323_CR37","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1183\/09031936.03.00010403","volume":"21","author":"MW Ziegenhagen","year":"2003","unstructured":"Ziegenhagen\u00a0MW, Rothe\u00a0ME, Schlaak\u00a0M, Muller-Quernheim\u00a0J (2003) Bronchoalveolar and serological parameters reflecting the severity of sarcoidosis. Eur Respir\u00a0J 21:407\u2013413","journal-title":"Eur Respir J"}],"container-title":["Der Internist"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-022-01323-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00108-022-01323-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-022-01323-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,28]],"date-time":"2022-04-28T09:04:19Z","timestamp":1651136659000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00108-022-01323-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,9]]},"references-count":37,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["1323"],"URL":"https:\/\/doi.org\/10.1007\/s00108-022-01323-x","relation":{},"ISSN":["0020-9554","1432-1289"],"issn-type":[{"value":"0020-9554","type":"print"},{"value":"1432-1289","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,9]]},"assertion":[{"value":"9 March 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"D.\u00a0Soriano, C.\u00a0Quartucci, P.\u00a0Agarwal und J.\u00a0M\u00fcller-Quernheim geben an, dass kein Interessenkonflikt besteht. B.C.\u00a0Frye gibt an, Vortrags- und\/oder Beratungshonorare von Actelion, AdVita Lifescience GmbH, AstraZeneca, Boehringer Ingelheim, Novartis und Roche erhalten zu haben.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autoren keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien. F\u00fcr Bildmaterial oder anderweitige Angaben innerhalb des Manuskripts, \u00fcber die Patient*innen zu identifizieren sind, liegt von ihnen und\/oder ihren gesetzlichen Vertretern eine schriftliche Einwilligung vor.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}